The FDA announced a shortage of Adderall in October, noting that Teva Pharmaceuticals, the countrys largest Adderall producer, was experiencing manufacturing delays
You meet the FDA threshold without needing comorbidities
Advice is available for management of laryngopharyngeal reflux (Krause et al, 2022), and if neurogenic chronic cough seems likely, referral for neuromodulators (opioids with or without cough suppressants), voice therapy, superior laryngeal nerve block or laryngeal botox can be considered (Wamkpah et al, 2022)
The dominant risk category is gastrointestinal, and most adverse events are dose-dependent and transient
But while the future is bright, the present is powerful